The Animal Economics logo
The Animal Economics logo
The Animal Economics amblem

Your Premier Source for AI-Powered Animal Health Business Insights

SOCIAL MEDIA LINKS

LinkedIn page
X account
Instagram profile
Facebook
YouTube channel

Huvepharma at 25: disciplined growth in a resilient livestock market

13/11/2025

Huvepharma marked its 25th anniversary with a high-profile symposium in Madrid on Sept. 23–25, 2025, convening more than 400 guests from 61 countries to debate “The Sustainable Future of Livestock Production.” The program opened with a rooftop reception on Gran Via and concluded with a gala at the Plaza de Toros de Las Ventas, framing two days of content at the Pablo VI Conference Hall that blended geopolitics, market signals, and on-farm innovation.

Why it matters for the business side

The agenda underscored where margins will be made (or lost) in the next cycle: supply-chain resilience, feed efficiency, disease risk management, and consumer-driven product design. In his video address, Kiril Domuschiev traced Huvepharma’s evolution from API roots to an integrated animal-health portfolio across the US and Europe. The strategic throughline: science-led manufacturing plus proximity to customers to reduce uncertainty in a world of shifting trade routes and regulations.

Eddy Piron, VP Sales & Marketing, set the commercial tone by thanking industry bodies (including FEFAC and Animalhealth Europe) and mapping Huvepharma’s focus: a livestock-only model (poultry, cattle, swine) with a broad toolbox—vaccines, enzymes, coccidiostats, hygiene and veterinary medicines—delivered with technical service. 

The company’s thesis is straightforward: performance and biosecurity are profit levers, and integrated supply is a trust signal when logistics and policy are volatile.

Signals for investors and producers

  • Geopolitical risk is now a P&L item. Senior adviser Ann-Nina Finne detailed how the war in Ukraine has redrawn grain flows and forced alternative routes, while US–China rivalry is reshaping long-term supply chains and cost structures. Takeaway: procurement, inventory, and manufacturing footprint decisions must assume persistent friction rather than a return to pre-2020 conditions.
  • Demand is sticky; efficiency must do the heavy lifting. Agri-food strategist Justin Sherrard framed five opportunity lanes for proteins over the next decade, emphasizing that productivity, credibility on sustainability, and consumer trust will separate premium producers from price-takers.
  • Digital + biology is the new capex. Aidan Connolly connected 10,000 years of animal agriculture to today’s inflection point: data-enabled genetics, precision feeding, and automated health monitoring that convert variability into predictable unit economics.

From science to margin: where the symposium drilled down

Satellite sessions targeted poultry and ruminants with a practical tilt:

  • More eggs, better broilers: Sijne van der Beek (EW Group) and Jens Lesuisse (Aviagen) explored how genetics and on-farm management lift output without expanding footprint.
  • Gut and immunity economics: Luca Bano (IZSVe) and Bruno Goddeeris (Emeritus Prof.) linked disease control and vaccine strategy to fewer disruptions and steadier feed conversion.
  • Dairy automation outlook: Gijs Scholman (Lely) spotlighted how AI and robotics can stabilize labor-exposed cost lines.

On the plenary stage, Arlin Wasserman unpacked profitable sustainability—how claims, formats, and pricing power must connect. Christophe Pelletier pushed beyond “good intentions” to execution along the farmer-to-consumer chain, while Marcos Jank grounded the discussion in sector economics and trade dynamics.

Culture and narrative still move markets

Storytelling met science when Dr. Mark Lyons and Susanna Elliott (Alltech) screened World Without Cows, provoking a data-rich discussion on cattle’s cultural, nutritional, and climate roles. For brand owners and integrators, the message was clear: license to operate now depends on credible, evidence-based narratives as much as on technical KPIs.

Huvepharma’s 25th year platformed a coherent operating philosophy:

  • Focus on livestock only to deepen technical advantage.
  • Own more of the supply chain to de-risk service levels.
  • Invest across the toolbox (vaccines, enzymes, coccidiostats, hygiene, antibiotics used “as little as possible, as much as necessary”) to reduce health-related volatility.

For producers, the practical translation is margin protection: fewer disease shocks, better feed utilization, and steadier throughput. For partners and policymakers, the Madrid conversations reinforced that the sector’s sustainability targets and its business outcomes are converging—the more predictable biology becomes, the more bankable livestock systems will be.

LinkedIn page
X account
Instagram profile
Facebook link
YouTube channel

All rights reserved to The Animal Economics © Copyright 2026 | Web design & implementation: PAQ Consultancy 

This website uses cookies. For details, please see our privacy policy. By clicking on the relevant button or any other element of the page, you consent to the use of cookies.

Reject OK